Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116583 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Miguel A Molina-Vila und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: ETOP IBCSG Partners Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain.
- ETOP IBCSG Partners Foundation, ETOP Statistical Center, Frontier Science Foundation-Hellas, Greece.
- Department of Pathology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, United Kingdom.
- Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
- Pathology, Aarhus University Hospital, Aarhus, Denmark.
- Pathomorphology Department, Medical University of Gdansk, Gdansk, Poland.
Förderung
- ETOP IBCSG Partners Foundation
Zitieren
APA
Molina-Vila, M. A., Tsourti, Z., Vervita, K., Bertran-Alamillo, J., García-Peláez, B., Kerr, K. M., Bubendorf, L., Madsen, L. B., Biernat, W., Stenzinger, A., Haberecker, M., Blackhall, F., Pokharel, S., Jordana-Ariza, N., Vives-Usano, M., Vagenknecht, P., Dafni, U., Kammler, R., Finn, S. P., …, & Rosell, R. (2026). Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116583
Vancouver
Molina-Vila MA, Tsourti Z, Vervita K, Bertran-Alamillo J, García-Peláez B, Kerr KM, et al. Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116583
BibTeX
@article{MolinaVila2026,
author = {Molina-Vila, Miguel A and Tsourti, Zoi and Vervita, Katerina and Bertran-Alamillo, Jordi and García-Peláez, Beatriz and Kerr, Keith M and Bubendorf, Lukas and Madsen, Line Bille and Biernat, Wojciech and Stenzinger, Albrecht and Haberecker, Martina and Blackhall, Fiona and Pokharel, Saraswati and Jordana-Ariza, Núria and Vives-Usano, Marta and Vagenknecht, Patrick and Dafni, Urania and Kammler, Roswitha and Finn, Stephen P and Peters, Solange and Stahel, Rolf A and Rosell, Rafael},
title = {Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116583}
}
EUVIMED